Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 6 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 11839598

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

  2. US 11819516

    Immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

  3. US 11807853

    Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  4. US 11793816

    Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B

    Northwestern University · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  5. US 11793825

    Biomarkers for predicting responsiveness to decitabine therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  6. US 11793806

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  7. US 11786542

    Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways

    Northwestern University · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  8. US 11786500

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  9. US 11786503

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  10. US 11779660

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11781156

    Plakophillin-2 gene therapy methods and compositions

    Tenaya Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  12. US 11779601

    Diagnostic methods for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  13. US 11759531

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  14. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    The Board of Regents of the University of Texas System · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  15. US 11730828

    Gene therapy for haploinsufficiency

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  16. US 11723922

    CXCR6-transduced T cells for targeted tumor therapy

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  17. US 11723929

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  18. US 11723923

    Methods of preparing T cells for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  19. US 11707536

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Takeda Pharmaceutical Company Limited · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  20. US 11699503

    Methods of identifying and treating patient populations amenable to cancer immunotherapy

    The Regents of the University of California · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted

  21. US 11690837

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  22. US 11679103

    Multi-targeting agents for Alzheimer's disease therapy

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  23. US 11680244

    Method for generating human dendritic cells for immunotherapy

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  24. US 11666574

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.